TNF and pancreatic neoplasm: Based on the aforementioned data and the fact that TLRs are central mediators of pro-inflammatory cytokine production, including TNF-α and IL-6, which play an important role in the pathogenesis of cancer cachexia[43, 51], we hypothesized that TLR blockade may be therapeutic in pancreatic cancer cachexia.